englishslovensky
  • Bohovič Roman, Demková Lucia, Cihová Marína, Školeková Svetlana, Ďuriníková Erika, Toro Lenka, Tyčiaková Silvia, Kozovská Zuzana, Matúšková Miroslava, Kučerová Lucia: 3D multicellular models reflect the efficiency of MSC-directed enzyme/prodrug treatment. Neoplasma 4, p. 521-530, 2015  [PubMed]  [DOI]
  • Školeková Svetlana, Matúšková Miroslava, Bohac Martin, Toro Lenka, Ďuriníková Erika, Tyčiaková Silvia, Demková Lucia, Gurský Ján, Kučerová Lucia: Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells. Cell Communication and Signaling 14 (1):4, p. 1-13, 2016  [PubMed]  [DOI]
  • Matúšková Miroslava, Kozovská Zuzana, Toro Lenka, Ďuriníková Erika, Tyčiaková Silvia, Čierna Zuzana, Bohovič Roman, Kučerová Lucia: Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases. Journal of experimental and clinical cancer research 34, p. 1-11, 2015  [DOI]
  • Kozovská Zuzana, Gábrišová Veronika, Kučerová Lucia: Malignant melanoma: diagnosis, treatment and cancer stem cells. Neoplasma 63, p. 510-517, 2016
  • Toro Lenka, Bohovič Roman, Matúšková Miroslava, Smolková Božena, Kučerová Lucia: Metastatic Ovarian Cancer Can Be Efficiently Treated by Genetically Modified Mesenchymal Stromal Cells. Stem Cells and Development 25, p. 1640-1651, 2016  [PubMed]
  • Kučerová Lucia, Demková Lucia, Školeková Svetlana, Bohovič Roman, Matúšková Miroslava: Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation. BMC Cancer 16 (1), p. 308-320, 2016  [PubMed]

Valid HTML 4.01 Transitional